Developer docs
API playgroundTry for free, no card

Search company profiles

VisionMed

Full company profile

uuid002xr2d

Namestring
VisionMed
Legal namestring
VisionMed
Websiteurl
visionmed.us
Company typeenum
Private
Founded yearint
2025
Descriptiontext

VisionMed is a US-based AI healthcare technology company founded in 2025 that develops EMMA™, a procedural intelligence platform designed to convert surgical and interventional procedure video into structured clinical documentation, event timelines, and analytics. The company targets hospital systems and surgical departments performing procedures across multiple specialties, including laparoscopic, endoscopic, arthroscopic/orthopedic, ophthalmologic, and robotic surgery. VisionMed explicitly positions EMMA™ as a clinician-in-the-loop documentation and post-procedure review layer, disavowing autonomous diagnostic, therapeutic, or intra-procedural guidance use cases.

EMMA™ is built on a proprietary agentic architecture that the company distinguishes from generic LLM wrappers. It performs multimodal perception across procedural video, optional audio, EHR data, and device/tool telemetry, and applies temporal analysis and context persistence to interpret video as a continuous process rather than isolated frames. Outputs include draft procedural documentation, timestamped event timelines, and quality/workflow analytics suitable for reporting, training, and review. The platform is device-agnostic and deployable via edge, cloud, or hybrid configurations without workflow disruption or vendor lock-in, and is complemented by an ancillary First Person Intelligence headset module that supplies clinician-eye perspective.

VisionMed operates a direct enterprise sales motion with a quote-based engagement model, generating revenue through subscription/enterprise licensing of the EMMA™ platform. Initial commercial availability was announced in April 2025 with early evaluations underway in select clinical environments. The company has no disclosed institutional funding, employs a small founding team of three co-founders plus a software engineer, robotics engineer, and a clinical orthopedic advisor, and has pursued strategic collaborations with a global robotic surgery society and an unnamed IRB-approved research institution to support training and research initiatives.

Short descriptiontext

VisionMed is a US-based AI healthcare company that develops EMMA™, an agentic procedural intelligence platform analyzing surgical video to produce structured clinical documentation. It serves hospital systems and surgical departments across multiple specialties via enterprise licensing, with initial commercial availability in April 2025.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
Markets served

Serves global market

Keyword5 values
procedural video analytics, AI surgical documentation, clinical intelligence platform, medical procedure automation, healthcare AI platform
Industry3 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAEANAC
Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code1 code
  • Custom Computer Programming Services541511
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical AI Video Analytics
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1EMMA™ Platform Subscription
TypeSubscription Recurring
Description

VisionMed generates revenue through enterprise licensing of its EMMA™ procedural intelligence platform. Early commercial availability was announced in April 2025 with early evaluations underway in select clinical environments. The platform is positioned for scalable enterprise integration across hospital systems and surgical departments.

visionmed.us
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1EMMA™
Description

AI-driven procedural intelligence platform that analyzes live or recorded procedural video to generate structured documentation, event timelines, and analytics.

visionmed.us
Core offering1 text field

VisionMed develops and sells EMMA™, an AI-driven procedural intelligence platform that analyzes live or recorded surgical and interventional video using multimodal perception and context persistence to generate clinician-reviewed structured documentation, event timelines, and quality/workflow analytics. The platform is device-agnostic, deployable across edge, cloud, or hybrid configurations, and integrates with existing clinical workflows and OEM ecosystems without disruption. It is supplemented by the First Person Intelligence ancillary headset providing clinician-eye perspective integration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Reduces documentation burden on clinicians, contributing to reduced physician burnout
Product overview1 text field

VisionMed offers a single unified AI platform called EMMA™ as its core product, augmented by an ancillary First Person Intelligence headset module. EMMA™ is a procedural intelligence platform that transforms raw procedural video data into structured documentation, event timelines, and analytics. The First Person Intelligence headset provides clinician-eye perspective integration with the core platform. Together, these products form the documentation, analytics, education, and intelligence layer for procedural medicine.

Product and service2 records
1EMMA™ Platform
CategoryClinical AI Video Analytics Platform
Description

AI-driven procedural intelligence platform that analyzes live or recorded procedural video using multimodal perception and context persistence to generate accurate, clinician-reviewed outputs including draft procedural documentation, event timelines with timestamps, and quality/workflow analytics. Integrates into existing clinical workflows and OEM ecosystems without disrupting how procedures are performed, with device-agnostic edge, cloud, or hybrid deployment.

2First Person Intelligence
CategoryHardware Add-on / Headset Integration
Description

Ancillary headset engineered by VisionMed that integrates with EMMA™ to provide clinician-eye perspective across surgical and interventional procedures, supporting procedural context and advanced analytics.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Unnamed IRB-Approved Research Institution
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

VisionMed partnered in an IRB-approved study evaluating AI applications in surgeon training for robotic surgery (January 2026). The study assesses AI applications in surgeon training workflows within robotic surgery environments.

visionmed.us
2Global Robotic Surgery Society
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

VisionMed initiated a collaboration with a global robotic surgery society in October 2025 to support training, education, and research initiatives using AI-enabled procedural video analysis. The partnership focuses on advancing surgical training and education through AI analysis of procedural video data.

visionmed.us
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Orthopedic surgical device leader with the Synergy.net ecosystem for arthroscopy and orthopedic procedural data. Adjacent incumbent in EMMA's orthopedic/arthroscopy use case, with strong surgeon relationships that complicate VisionMed's GTM in those specialties.

TypeBroad incumbent
Description

Medtech incumbent with the Mako robotic-assisted surgery platform and growing surgical-data and analytics offerings. Competes for hospital budgets in surgical AI and has the installed base and capital to scale procedural intelligence rapidly.

TypeDirect peer
Description

AI-powered surgical video analytics platform that ingests operative footage to deliver intraoperative decision support, postoperative review, and surgeon-performance analytics. Direct overlap with EMMA's procedural intelligence, computer-vision-based event detection, and quality/training use cases in the OR.

TypeBroad incumbent
Description

Da Vinci robotic surgery platform leader with a deep installed base of procedure-capture hardware and an emerging portfolio of AI-enabled surgical intelligence (e.g., Case Insights). Closest comparable in combining procedural video capture with AI-driven analytics at scale.

TypeBroad incumbent
Description

AI-driven surgical training and procedure-planning platform acquired by Medtronic. Comparable in the procedural-intelligence and surgical-training use cases VisionMed targets, now embedded inside a major medtech incumbent with substantially greater distribution.

TypeDirect peer
Description

AI and computer-vision company building real-time surgical guidance and visualization overlays for laparoscopic and endoscopic procedures. Directly competes in procedural video AI and shares VisionMed's hardware-plus-software model (hardware attach + software intelligence).

TypeEmerging player
Description

VR/AR surgical visualization platform converting imaging and procedural data into immersive 360° reconstructions for planning, training, and patient engagement. Adjacent in using rich procedural imagery to generate clinical intelligence and in targeting training/research workflows.

TypeOthers
Description

Alphabet's health-tech arm with prior strategic interest in surgical AI (legacy Verb Surgical JV with J&J). Adjacent ecosystem player and potential strategic partner/investor given VisionMed's Google event visibility.

TypeDirect peer
Description

Telepresence and augmented-reality platform for the operating room that captures procedural video, enables remote collaboration, and increasingly layers in AI analytics. Comparable in targeting hospital systems and surgical departments with a device-agnostic OR video workflow play.

TypeBroad incumbent
Description

Global medtech incumbent with the Hugo robotic surgery platform and Touch Surgery AI assets. Represents both a likely competitor (native AI documentation in its robotic ecosystem) and a potential strategic acquirer of VisionMed-class technology.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VisionMed

Clinical AI Video Analyticsvisionmed.us

VisionMed is a US-based AI healthcare company that develops EMMA™, an agentic procedural intelligence platform analyzing surgical video to produce structured clinical documentation. It serves hospital systems and surgical departments across multiple specialties via enterprise licensing, with initial commercial availability in April 2025.

What VisionMed does

VisionMed is a US-based AI healthcare technology company founded in 2025 that develops EMMA™, a procedural intelligence platform designed to convert surgical and interventional procedure video into structured clinical documentation, event timelines, and analytics. The company targets hospital systems and surgical departments performing procedures across multiple specialties, including laparoscopic, endoscopic, arthroscopic/orthopedic, ophthalmologic, and robotic surgery. VisionMed explicitly positions EMMA™ as a clinician-in-the-loop documentation and post-procedure review layer, disavowing autonomous diagnostic, therapeutic, or intra-procedural guidance use cases.

EMMA™ is built on a proprietary agentic architecture that the company distinguishes from generic LLM wrappers. It performs multimodal perception across procedural video, optional audio, EHR data, and device/tool telemetry, and applies temporal analysis and context persistence to interpret video as a continuous process rather than isolated frames. Outputs include draft procedural documentation, timestamped event timelines, and quality/workflow analytics suitable for reporting, training, and review. The platform is device-agnostic and deployable via edge, cloud, or hybrid configurations without workflow disruption or vendor lock-in, and is complemented by an ancillary First Person Intelligence headset module that supplies clinician-eye perspective.

VisionMed operates a direct enterprise sales motion with a quote-based engagement model, generating revenue through subscription/enterprise licensing of the EMMA™ platform. Initial commercial availability was announced in April 2025 with early evaluations underway in select clinical environments. The company has no disclosed institutional funding, employs a small founding team of three co-founders plus a software engineer, robotics engineer, and a clinical orthopedic advisor, and has pursued strategic collaborations with a global robotic surgery society and an unnamed IRB-approved research institution to support training and research initiatives.

VisionMed firmographics

Firmographics
Name
VisionMed
Legal name
VisionMed
Website
https://visionmed.us
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
11–50 employees
Short description
VisionMed is a US-based AI healthcare company that develops EMMA™, an agentic procedural intelligence platform analyzing surgical video to produce structured clinical documentation. It serves hospital systems and surgical departments across multiple specialties via enterprise licensing, with initial commercial availability in April 2025.
Ownership category
akta.pro rank

VisionMed industry classification

Industry
Product category
Clinical AI Video Analytics
NAICS
Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAEANAC
Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Procedural video analytics
  • AI surgical documentation
  • Clinical intelligence platform
  • Medical procedure automation
  • Healthcare AI platform

VisionMed business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. EMMA™ Platform Subscription: VisionMed generates revenue through enterprise licensing of its EMMA™ procedural intelligence platform. Early commercial availability was announced in April 2025 with early evaluations underway in select clinical environments. The platform is positioned for scalable enterprise integration across hospital systems and surgical departments.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

VisionMed product offering

Product offering

Core offering

VisionMed develops and sells EMMA™, an AI-driven procedural intelligence platform that analyzes live or recorded surgical and interventional video using multimodal perception and context persistence to generate clinician-reviewed structured documentation, event timelines, and quality/workflow analytics. The platform is device-agnostic, deployable across edge, cloud, or hybrid configurations, and integrates with existing clinical workflows and OEM ecosystems without disruption. It is supplemented by the First Person Intelligence ancillary headset providing clinician-eye perspective integration.

Product overview

VisionMed offers a single unified AI platform called EMMA™ as its core product, augmented by an ancillary First Person Intelligence headset module. EMMA™ is a procedural intelligence platform that transforms raw procedural video data into structured documentation, event timelines, and analytics. The First Person Intelligence headset provides clinician-eye perspective integration with the core platform. Together, these products form the documentation, analytics, education, and intelligence layer for procedural medicine.

Differentiator

Problem solved

Functional benefit

Brands

  • EMMA™: AI-driven procedural intelligence platform that analyzes live or recorded procedural video to generate structured documentation, event timelines, and analytics.

Products and services

  • EMMA™ Platform AI-driven procedural intelligence platform that analyzes live or recorded procedural video using multimodal perception and context persistence to generate accurate, clinician-reviewed outputs including draft procedural documentation, event timelines with timestamps, and quality/workflow analytics. Integrates into existing clinical workflows and OEM ecosystems without disrupting how procedures are performed, with device-agnostic edge, cloud, or hybrid deployment.
  • First Person Intelligence Ancillary headset engineered by VisionMed that integrates with EMMA™ to provide clinician-eye perspective across surgical and interventional procedures, supporting procedural context and advanced analytics.

Quantifiable outcome

  • Reduces documentation burden on clinicians, contributing to reduced physician burnout

Companies that use VisionMed

Customer profile

Segments3 records

Ideal customer profiles2 records

VisionMed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

VisionMed partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • Unnamed IRB-Approved Research InstitutionminorStrategic or Co-development Partner · 1 January 2026VisionMed partnered in an IRB-approved study evaluating AI applications in surgeon training for robotic surgery (January 2026). The study assesses AI applications in surgeon training workflows within robotic surgery environments.
  • Global Robotic Surgery SocietycoreStrategic or Co-development Partner · 1 October 2025VisionMed initiated a collaboration with a global robotic surgery society in October 2025 to support training, education, and research initiatives using AI-enabled procedural video analysis. The partnership focuses on advancing surgical training and education through AI analysis of procedural video data.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

VisionMed competitors and assessment

Company assessment

Broad incumbents

  • Arthrex: Orthopedic surgical device leader with the Synergy.net ecosystem for arthroscopy and orthopedic procedural data. Adjacent incumbent in EMMA's orthopedic/arthroscopy use case, with strong surgeon relationships that complicate VisionMed's GTM in those specialties.
  • Stryker: Medtech incumbent with the Mako robotic-assisted surgery platform and growing surgical-data and analytics offerings. Competes for hospital budgets in surgical AI and has the installed base and capital to scale procedural intelligence rapidly.
  • Intuitive Surgical: Da Vinci robotic surgery platform leader with a deep installed base of procedure-capture hardware and an emerging portfolio of AI-enabled surgical intelligence (e.g., Case Insights). Closest comparable in combining procedural video capture with AI-driven analytics at scale.
  • Touch Surgery (Digital Surgery, now Medtronic): AI-driven surgical training and procedure-planning platform acquired by Medtronic. Comparable in the procedural-intelligence and surgical-training use cases VisionMed targets, now embedded inside a major medtech incumbent with substantially greater distribution.
  • Medtronic: Global medtech incumbent with the Hugo robotic surgery platform and Touch Surgery AI assets. Represents both a likely competitor (native AI documentation in its robotic ecosystem) and a potential strategic acquirer of VisionMed-class technology.

Direct peers

  • Theator: AI-powered surgical video analytics platform that ingests operative footage to deliver intraoperative decision support, postoperative review, and surgeon-performance analytics. Direct overlap with EMMA's procedural intelligence, computer-vision-based event detection, and quality/training use cases in the OR.
  • Activ Surgical: AI and computer-vision company building real-time surgical guidance and visualization overlays for laparoscopic and endoscopic procedures. Directly competes in procedural video AI and shares VisionMed's hardware-plus-software model (hardware attach + software intelligence).
  • Proximie: Telepresence and augmented-reality platform for the operating room that captures procedural video, enables remote collaboration, and increasingly layers in AI analytics. Comparable in targeting hospital systems and surgical departments with a device-agnostic OR video workflow play.

Emerging players

  • Surgical Theater: VR/AR surgical visualization platform converting imaging and procedural data into immersive 360° reconstructions for planning, training, and patient engagement. Adjacent in using rich procedural imagery to generate clinical intelligence and in targeting training/research workflows.

Others

  • Verily (Alphabet): Alphabet's health-tech arm with prior strategic interest in surgical AI (legacy Verb Surgical JV with J&J). Adjacent ecosystem player and potential strategic partner/investor given VisionMed's Google event visibility.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

VisionMed social profiles

Digital presence

VisionMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VisionMed leadership team

Management profile

Number of profiles

Profiles6 records

VisionMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VisionMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VisionMed

What does VisionMed do?

VisionMed develops and sells EMMA™, an AI-driven procedural intelligence platform that analyzes live or recorded surgical and interventional video using multimodal perception and context persistence to generate clinician-reviewed structured documentation, event timelines, and quality/workflow analytics. The platform is device-agnostic, deployable across edge, cloud, or hybrid configurations, and integrates with existing clinical workflows and OEM ecosystems without disruption. It is supplemented by the First Person Intelligence ancillary headset providing clinician-eye perspective integration.

Is VisionMed a public or private company?

VisionMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was VisionMed founded?

VisionMed was founded in 2025. It employs 11 to 50 people.

How does VisionMed make money?

One revenue line is on record: EMMA™ Platform Subscription.

Who are VisionMed's main competitors?

Broad incumbents on record are Arthrex, Stryker, Intuitive Surgical, Touch Surgery (Digital Surgery, now Medtronic) and Medtronic. Direct peers are Theator, Activ Surgical and Proximie. Surgical Theater is listed as an emerging player. Verily (Alphabet) is listed as an others.

Does VisionMed have an API?

No public API is recorded for VisionMed.

What industry is VisionMed in?

VisionMed's product category is Clinical AI Video Analytics. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of BPAEAHAF, AI/ML Engineering & Model Development Services. Its NAICS code is 541511 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireVisionMed Adds Ophthalmology and Neurosurgery Expertise to Medical Advisory BoardVisionMed appointed Omar Shakir and Omar Choudhri to its medical advisory board to expand expertise in ophthalmology and neurosurgery. The appointments aim to guide EMMA's development for procedural video and imaging workflows. The company's platform is being evaluated across multiple specialties.EIN PresswireVisionMed Appoints Tony Burns as Strategic Advisor, Ambulatory & Office-Based SurgeryVisionMed appointed Tony Burns as Strategic Advisor, Ambulatory & Office-Based Surgery, bringing over three decades of experience in ambulatory surgery centers and office-based settings. He will advise on site-of-care dynamics and EMMA's integration into high-volume procedural settings. The appointment supports EMMA's expansion across hospitals, ambulatory centers, and office-based environments.openPR.comLeading Companies Fueling Innovation and Growth in the Artificial Intelligence (AI)-Enhanced Surgical Video Analytics MarketThe AI-enhanced surgical video analytics market is projected to reach $2.14 billion by 2030, growing at a compound annual growth rate of 23.8%, driven by AI-powered real-time analytics, integration with robotic surgery platforms, and rising demand for outcome-focused healthcare. In a notable collaboration, VisionMed (South Korea) partnered with The Robotic Global Surgical Society (France) in October 2025 to advance AI-powered computer vision technologies for surgical documentation and education. Additionally, Medtronic introduced a real-time surgical broadcasting service across over 20 countries in April 2024, integrating 14 AI algorithms to support post-operative analysis, virtual coaching, and surgical training.Ortho Spine NewsVisionMed and TROGSS Partner to Advance Global Surgical Education with AI Video Analysis – Ortho Spine NewsVisionMed and TROGSS announced a partnership to integrate VisionMed's EMMA AI platform into TROGSS' robotic surgery education and training programs. The collaboration includes training licenses, technical support, and sponsorship of the TROGSS Intercontinental Congress in Luxembourg in July 2026. Both organizations will also collaborate on research and publications on AI video analysis in surgical education.Business & FinancialVisionmed Launches Breakthrough AI Video Analysis Technology For Medical Procedure Note GenerationVisionMed entered commercial launch of its EMMATM AI platform, which analyzes medical procedure videos to generate draft operative notes. The company is collaborating with select flagship hospitals in an early access program, with future enhancements awaiting FDA 510(k) clearance.